Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A 1 receptor agonist

By Von Lubitz D.K.J.E.   Lin R.C.-S.   Bischofberger N.   Beenhakker M.   Boyd M.   Lipartowska R.   Jacobson K.A.  

European Journal of Pharmacology, Vol. 369, Iss. 3, 1999-03 ,pp. : 313-317

Elsevier

Access to resources Recommend Favorite

Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A 3 receptor agonist, IB-MECA

By Maddock H.L.   Gardner N.M.   Khandoudi N.   Bril A.   Broadley K.J.  

European Journal of Pharmacology, Vol. 477, Iss. 3, 2003-09 ,pp. : 235-245

Elsevier

Access to resources Recommend Favorite

BN-063, a newly synthesized adenosine A 1 receptor agonist, attenuates myocardial reperfusion injury in rats

By Yen-Mei L.   Joen-Rong S.   Mao-Hsiung Y.  

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 251-256

Elsevier

Access to resources Recommend Favorite

A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

By Nakamura M.   Zhao Z.-Q.   Clark K.L.   Velez D.V.   Guyton R.A.   Vinten-Johansen J.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Differential effects of selective adenosine A 1 and A 2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats

By Rimondini R.   Ferre S.   Gimenez-Llort L.   Ogren S.O.   Fuxe K.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite